Dr. Nokin’s work is critical in identifying the metabolic drivers that facilitate therapeutic resistance in lung and prostate cancers.

Academic Titles & Degrees:  MD and PhD (University of Liège); MSc in Biomedical Sciences.

Current Executive & Clinical Appointments:  Assistant Professor at the Laboratory of Tumor and Developmental Biology (GIGA-Cancer), University of Liège.

Research Axes & Leadership: Investigation of metabolic vulnerabilities and therapeutic resistance in lung adenocarcinoma; study of Dentin Matrix Protein 1 (DMP1) in human prostate cancer.

High-Impact Publications & Awards:   Nature Communications, Cancer Research, Clinical Cancer Research, Journal for Immunotherapy of Cancer.